About Us Reports Knowledge Center Services Blog IBO Newsletter Login Blog - Latest News You are here: Home / Mesa Labs acquisition of Agena Bioscience shows importance of clinical diagnostic systems / Blog / Mesa Labs acquisition of Agena Bioscience shows importance of clinical... Mesa Labs acquisition of Agena Bioscience shows importance of clinical diagnostic systems September 24, 2021/0 Comments/in Blog, Featured Articles 3 /by Wes Bova Clinical laboratory diagnostics has become an important area of investment and business transactions. Recently, Mesa Laboratories, a biotech company focused on quality control solutions for pharmaceutical, healthcare, and medical devices, announced the acquisition of Agena Bioscience for a cash purchase price of $300 million. According to the press release, Mesa is expected to pay for the acquisition through cash on hand and credit. The acquisition is expected to be completed by the end of the year pending regulatory approval and met conditions of the agreement. With current yearly revenues around $65 million and an additional $3-$5 million in COVID-19 revenues, Agena Bioscience is expected to greatly contribute to Mesa Laboratories’ solutions lineup. An important consideration in this deal was the MassArray system, a combination platform of MALDI-TOF mass spectroscopy and multiplex PCR. Built to test for and identify clinically relevant mutations, the MassArray system has found a host of important applications in the clinical diagnostics setting, including a Dx Lung Panel, a Dx colon panel, and more recently an Emergency Use Authorization (EUA) for the iPLEX Pro SARS-CoV-2 Panel for qualitative detection of the coronavirus that causes COVID-19. The upside for this system is throughput, with the system able to run more than 6,000 samples in one day. The success of the MassArray system in clinical diagnostics is indicative of a broader trend for MALDI-TOF systems that have been approved for clinical use in several regions including the United States, Europe, and China. Clinical diagnostics has been addressed by MALDI-TOF with offerings from several companies besides Agena Bioscience. bioMérieux offers the VITEK-MS, an FDA cleared, and CE marked device that excels at microbial identification and has a large library of clinically relevant tests. Bruker offers the MALDI Biotyper CA, another automated system like the VITEK-MS that excels at bacterial identification, with constant updates to their reference libraries for new species of a variety of bacteria, anaerobes, and yeast. Further data and analysis relating to this active market can be found in SDI’s latest publication, the 2021 Mass Spectrometry Market for Clinical Applications, which provides an in-depth look at the rapidly growing clinical market for mass spectrometry. This report contains market size, growth rates, vendor shares, and commentary for select technologies operating in the clinical mass spectrometry marketplace. These technologies include GC/MS, LC/MS-MS, Q-TOF LC/MS, FT/MS & Ion Trap, and ICP-MS. The report also provides the latest information on new IVD approvals of mass spec products, new system introductions, and supplier collaborations. Tags: acquisition, agena bioscience, clinical diagnostics, mesa labs Share this entry 0 REPLIES Leave a Reply Want to join the discussion? Feel free to contribute! Name * Email * Website Save my name, email, and website in this browser for the next time I comment. SEARCH PREVIOUS POSTS Select Month October 2021 (1) September 2021 (2) August 2021 (1) June 2021 (1) May 2021 (1) April 2021 (2) March 2021 (3) January 2021 (1) December 2020 (2) November 2020 (4) October 2020 (3) September 2020 (6) August 2020 (3) July 2020 (3) June 2020 (6) May 2020 (2) April 2020 (2) March 2020 (8) February 2020 (1) November 2019 (2) October 2019 (2) September 2019 (4) August 2019 (1) July 2019 (3) June 2019 (2) May 2019 (2) April 2019 (3) March 2019 (3) February 2019 (2) January 2019 (2) December 2018 (1) October 2018 (4) September 2018 (4) August 2018 (5) July 2018 (1) June 2018 (1) February 2018 (1) September 2014 (1) RECENT POSTS Pharma/Bio Trends Supporting Demand for Analytical Instrumentation Trends in the Laboratory Instrument Service Market Mesa Labs acquisition of Agena Bioscience shows importance of clinical diagnostic systems Laboratory Consumables a Major Area of Industry Acquisition Activity Europe 2021: The Market for Analytical & Life Science Instrumentation INDUSTRY NEWS Illumina Inc. (ILMN) Latest News and Helpful Information - The Baxter Report December 3, 2021 Array Market Latest Development Report 2021-2028 : Naffymetrix, Illumina, Roche ... - MW Creators December 3, 2021 Biotechnology Instrumentation Market Past Research, Deep Analysis and Present Data With ... December 3, 2021 Atomic Absorption Spectroscopy Market to See Thriving Worldwide - MW Creators December 3, 2021 Global Female and Neonatal Diagnostic Devices Market 2021 Future Statistics – Hologic ... December 3, 2021 Global Fetal and Neonatal Monitoring Devices Market 2021 Key Strategic - Virtual-Strategy Magazine December 3, 2021 Anesthesia Ventilators Market Competition, Opportunities and Challenges, Market Players ... December 3, 2021 Global Contrast Agents Market 2021 Top Most Key Players |Bayer, GE Healthcare, Bracco ... December 3, 2021 CONTACT US SDi Corporate Office 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States Send us a message! FOLLOW US! PAY INVOICE Pay an Invoice by Credit Card PRESS RELEASES Europe 2021: The Market for Analytical & Life Science Instrumentation June 14, 2021 1:52 pm 2 Billion Dollar Tools Market for Cell and Gene Therapy, Says Report April 27, 2021 7:19 am SDi Publishes Global Assessment Report: Laboratory Analytical and Life Science Instrument Market Will Exceed $69 Billion in 2021 March 4, 2021 6:46 am SITEMAP Home About Us Reports Services Blog Careers Clients Meet the Team YOUR DATA AND PRIVACY View our Privacy Policy GDPR Statement ABOUT US Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients. Visit Science and Medicine Group © Copyright - Strategic Directions By continuing to browse the site, you are agreeing to our use of cookies.OK